taraxerol has been researched along with dinoprostone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Q; Li, G; Lü, C; Xu, H; Yao, X | 1 |
1 other study(ies) available for taraxerol and dinoprostone
Article | Year |
---|---|
Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2; Cytokines; Dinoprostone; Down-Regulation; Inflammation; Lipopolysaccharides; Macrophages; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Oleanolic Acid; Oncogene Protein v-akt; RNA, Messenger | 2013 |